Novel Coronavirus in U.S. Underscores Need for Comprehensive Preparedness

The first U.S. patient to be diagnosed with the novel coronavirus first reported in Wuhan, China highlights needs for expanded readiness to detect, prevent and respond to this virus and those to come, at home and abroad.

Ten Additional Members Inducted to 2019 FIDSA Awardee List

The IDSA Board of Directors has added ten members to those receiving the Fellow of IDSA Designation. FIDSA is the ID profession’s highest honor given to those who demonstrate excellence and leadership in the field. See the full list of 2019 FIDSA designees.

CORRECTION: Antibiotic Company Starts Bankruptcy Proceedings; Highlights Urgent Need for Investment in Infection Fighting Drugs

The bankruptcy filing announced today by antibiotic maker Melinta once again highlights the daunting challenges facing research and development of new infection-fighting drugs.

FY 2020 Spending Bill Funds Critical Initiatives While Neglecting Urgent Priorities

The spending bill passed today is a welcome step forward. Allocations in the bill will strengthen public health and research efforts during the year ahead and will provide critical support for important goals.

House Drug Pricing Bill Serves Patients, Public Health

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies for conditions including HIV and hepatitis C.

Flu Preparedness Hearing Opens Opportunities for Vaccine, AMR Action

Today’s subcommittee hearing on U.S. preparedness and responses for the 2019-2020 flu season offers an important opportunity to examine and act on gaps and challenges exacerbating the public health threats of seasonal influenza outbreaks.

Hepatitis C Guidance Updated was recently revised to reflect important developments in the identification and management of chronic hepatitis C.

This World AIDS Day Finds Us at a Crossroads

This World AIDS Day marks a promising and unprecedented point in a quest begun nearly four decades ago to end the global public health threat of HIV through science and solidarity.

CDC Antibiotic Resistance Threats Report Shows Impacts of Federal Investments, Continued Gaps

The Antibiotic Resistance Threats Report released by the CDC today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.

For Patients with Sepsis, an Infectious Disease Expert May Reduce the Risk of Death

Among patients with severe sepsis, early consultation with an ID specialist was associated with 40 percent lower mortality, a new study in Open Forum Infectious Diseases finds.

Journal Articles Explore Fatal Consequences of Immigrant Detention Policies, Conditions

Clinical Infectious Diseases articles examine child deaths at U.S. immigrant detention centers.

New STD Data Represent Urgent Call for Action

The continued steep increase in incidence of sexually transmitted diseases reported by the CDC Tuesday, is a cause for deep concern about dangerous gaps in our public health infrastructure.